Back
Citigroup, Inc. Vs. Rhythm Pharmaceuticals, Inc. Industry Stock Comparison
Buy
79
C
Citigroup, Inc.
Last Price:
$111.81
Seasonality Move:
2.27%
Buy
67
RYTM
Rhythm Pharmaceuticals, Inc.
Last Price:
$113.50
Seasonality Move:
-9.01%
Buy
79
Citigroup, Inc. (C)
is a Buy
Is Citigroup, Inc. a Buy, Sell or Hold?
-
The current Citigroup, Inc. [C] share price is $111.80. The Score for C is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
-
C is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
67
Rhythm Pharmaceuticals, Inc. (RYTM)
is a Buy
Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $113.56. The Score for RYTM is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
-
RYTM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
C Stock Price Chart
What is Citigroup, Inc.'s stock price today?
-
The Citigroup, Inc. share price today is $111.80Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and C is experiencing slight selling pressure.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals, Inc.'s stock price today?
-
The Rhythm Pharmaceuticals, Inc. share price today is $113.56Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight selling pressure.
C Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.02 | Buy |
| Relative Strength Index (14 RSI): | 75.47 | Buy |
| Chaikin Money Flow: | -5113412 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (99.07 - 108.03) | Buy |
| Bollinger Bands (100): | (94.42 - 103.42) | Buy |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.67 | Buy |
| Relative Strength Index (14 RSI): | 59.45 | Buy |
| Chaikin Money Flow: | -357754 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (98.81 - 108.61) | Buy |
| Bollinger Bands (100): | (93.91 - 107.83) | Buy |
C Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 109.55 | Buy |
| 20-day SMA: | 104.11 | Buy |
| 50-day SMA: | 101.11 | Buy |
| 200-day SMA: | 86.89 | Buy |
| 8-day EMA: | 109.3 | Buy |
| 20-day EMA: | 105.86 | Buy |
| 50-day EMA: | 102.25 | Buy |
| 200-day EMA: | 90.27 | Buy |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 107.1 | Buy |
| 20-day SMA: | 105.06 | Buy |
| 50-day SMA: | 105.14 | Buy |
| 200-day SMA: | 81.74 | Buy |
| 8-day EMA: | 108.55 | Buy |
| 20-day EMA: | 106.16 | Buy |
| 50-day EMA: | 103.93 | Buy |
| 200-day EMA: | 86.65 | Buy |
Citigroup, Inc. Earnings Growth & C Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.76 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.99 per share, and an increase next year of $1.83 per share.
Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and an increase next year of $0.56 per share.
Citigroup, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||